NPM1 Gene NPM1 Selective Sequencing of Exon 11 Genetic Test
Welcome to DNA Labs UAE, where we offer the NPM1 gene selective sequencing of exon 11 genetic test. This test focuses on sequencing only the 11th exon of the NPM1 gene, which is involved in various cellular processes such as cell division and gene expression regulation.
Test Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Cancer
Doctor
Oncologist
Test Department
Genetics
Pre Test Information
Before undergoing the NPM1 gene selective sequencing of exon 11 NGS genetic DNA test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the NPM1 gene. This information will help in the interpretation of the test results.
Test Details
The NPM1 gene, also known as Nucleophosmin 1, is responsible for producing a protein called nucleophosmin. This protein plays a role in cell division and gene expression regulation. The selective sequencing of exon 11 refers to a specific type of genetic test that focuses on analyzing the 11th exon of the NPM1 gene. Exons are regions of a gene that contain the coding sequence for protein production. By selectively sequencing exon 11, this test aims to identify any variations or mutations within this specific region of the NPM1 gene.
NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA or RNA. In the context of genetic testing, NGS can be used to analyze multiple genes or specific regions of genes simultaneously, providing a comprehensive assessment of genetic variations or mutations.
The NPM1 gene selective sequencing of exon 11 NGS genetic test utilizes NGS technology to specifically analyze exon 11 of the NPM1 gene for any genetic variations or mutations. This test is particularly useful in diagnosing or monitoring certain types of cancer, as mutations in the NPM1 gene have been associated with malignancies such as acute myeloid leukemia (AML).
Test Name | NPM1 Gene NPM1 selective sequencing of exon 11 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NPM1 Gene NPM1, selective sequencing of exon 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NPM1 Gene NPM1, selective sequencing of exon 11 NGS Genetic DNA Test gene NPM1 |
Test Details |
The NPM1 gene, also known as Nucleophosmin 1, is a gene that provides instructions for making a protein called nucleophosmin. This protein is involved in various cellular processes, including cell division and the regulation of gene expression. Selective sequencing of exon 11 refers to a specific type of genetic test that focuses on sequencing only the 11th exon of the NPM1 gene. Exons are specific regions of a gene that contain the coding sequence for producing a protein. By selectively sequencing exon 11, this test aims to identify any variations or mutations within this particular region of the NPM1 gene. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA or RNA. In the context of genetic testing, NGS can be used to analyze multiple genes or specific regions of genes simultaneously, providing a comprehensive assessment of genetic variations or mutations. Therefore, the NPM1 gene selective sequencing of exon 11 NGS genetic test involves using NGS technology to specifically analyze exon 11 of the NPM1 gene for any genetic variations or mutations. This test can be used in various clinical settings, such as diagnosing or monitoring certain types of cancer, as mutations in the NPM1 gene have been associated with certain malignancies, including acute myeloid leukemia (AML). |